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Available online 25 June 2013Angiotensin I converting enzyme (ACE) inhibitory activity of peptides derived from the
hydrolysis of sarcoplasmic and myofibrillar porcine proteins by the action of Lactobacillus
sakei CRL1862 and Lactobacillus curvatus CRL705 (whole cells + cell free extracts) was
investigated at 30 °C for 36 h. The protein hydrolysates were subjected to RP-HPLC in
order to fractionate the extracts for further evaluation of ACE inhibitory activity. Bioactive
fractions were only found from the hydrolysis of sarcoplasmic proteins by both assayed
lactobacilli strains. Identification of peptides contained in the bioactive fractions was
carried out by tandem mass spectrometry using a nanoLC-ESI-QTOF instrument and the
mascot search engine. From the four most active fractions obtained, a total of eighteen and
fifty peptides were characterized from L. sakei CRL1862 and L. curvatus CRL705 protein
hydrolysates, respectively. The sequence FISNHAYwas generated by the proteolytic activity
of the two lactobacilli species. Sequence similarity analyses between the peptides identified
in this study and those previously identified as ACE inhibitory peptides and detailed in the
BIOPEP database were outlined. Results suggest that meat-borne Lactobacillus were able to
generate peptides with ACE inhibitory activity, highlighting their potential to be used in the
development of functional fermented products.
Biological significance
The results of this study would enable the obtention of porcine functional foods by applying
lactic acid bacteria generating bioactive peptides. ACE inhibitory peptides obtained by the
hydrolytic action of L. curvatus CRL705 and L. sakei CRL1862 on sarcoplasmic proteins were
analyzed. Among them, the peptide FISNHAY exhibited the highest activity and its
sequence has not yet been reported.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.Keywords:
Proteomics
Angiotensin I converting enzyme
Pork proteins
Bioactive peptides
Meat-borne Lactobacillus1720.
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Food proteins have long been recognized for their nutritional
and functional properties. Nutritional properties are associat-
ed with their amino acid content in conjunction with the
physiological utilization of specific amino acids upon diges-
tion and absorption [1,2]. On the other hand, the functional
properties of proteins are related to their contribution to
physiochemical and sensory properties of foods [3]. In recent
years, a considerable amount of research has also focused on
the release of bioactive peptides which are encrypted within
the primary structure of food proteins, in view to investigate
such peptides as functional food ingredients aimed at health
maintenance.
A variety of biologically active peptides derived from food
proteins have been identified [4]. Inhibitors of angiotensin I
converting enzyme (ACE) have attracted particular attention for
their ability to prevent hypertension. Angiotensin I converting
enzyme is a dipeptidyl carboxypeptidase [EC 3.4.15.1] that
not only catalyzes conversion of angiotensin I to angiotensin II
causing hypertension, but also inactivates bradykinin, a
vasodilatory peptide [5]. Consequently, those compounds
capable to inactivate the activity of this enzymewould generate
the opposite effect, i.e. a decrease of blood pressure. Many ACE
inhibitor peptides have been isolated from enzymatically
digested food proteins such as casein, whey proteins, plant
proteins [6] and muscle sources [7]. On the other hand,
proteolytic release of bioactive sequences by lactic acid bacteria
(LAB) has been debated recently due to the great advantages of
using food grademicroorganisms to enrich foodswith bioactive
substances [8]. As reported in the literature, potent ACE
inhibitory peptides were produced during milk fermentation
or casein proteolysis by lactic acid bacteria proteases [8–10]
however this effect has been poorly documented from meat
proteins. Although, a study has been performed on marine
proteins, particularly during fermentation of shrimp (Acetes
chinensis) with Lactobacillus fermentum SM605 inwhich three ACE
inhibitory peptides were identified [11].
In this work, L. curvatus CRL705 and L. sakei CRL1862 isolated
from traditional Argentinean sausages [12,13] were used as
proteolytic enzyme sources to evaluate the generation of ACE
inhibitory peptides from porcine skeletal muscle proteins
Muscle foods serve as interesting substrates for investigation
into the potential presence of bioactive peptides, specifically
ACE inhibitory peptides to design new healthy meat products.2. Materials and methods
2.1. Bacterial strains and culture conditions
Lactobacillus curvatus CRL705 and Lactobacillus sakei CRL1862
strains from CERELA culture collection, previously isolated
from traditional sausages [12,13], were used to generate
bioactive peptides. The strains were routinely grown in MRS
broth (Britania, Argentina) at 30 °C for 18 h and then
maintained at −80 °C in 15% (vol/vol) glycerol. Counts were
carried out using Plate Count Agar for total mesophiles and
MRS agar for LAB at 30 °C during 48 h.2.2. Preparation of L. curvatus CRL705 and L. sakei
CRL1862 cell suspensions and meat protein extracts
Whole-cell (WC) suspensions (150 ml) from L. sakei CRL1862
and L. curvatus CRL705 grown to logarithmic phase were
collected by centrifugation (10,000 rpm, 20 min, 4 °C), washed
twice in 20 mM phosphate buffer (pH 7.0), and resuspended in
the same buffer (20% of initial volume). The cell free extracts
(CFE) were obtained by the procedure described by Sanz et al.
[14]. Meat protein extracts were obtained from porcine
longissimus dorsi sarcoplasmic and myofibrillar proteins ac-
cording to Fadda et al. [15]. The protein contents of sarcoplas-
mic and myofibrillar extracts determined by the method of
Bradford [16] using bovine serum albumin as standard were
2.50 and 0.60 mg/ml, respectively. For both extracts, sterility
was confirmed by determining the absence of bacterial
growth on Plate Count Agar (Merck, Argentina) incubated
overnight at 30 °C.
2.3. Protein hydrolysis and peptide analysis
For each meat protein extract (sarcoplasmic or myofibrillar) a
combination (1:1) of CFE + WC suspension of L. curvatus
CRL705 or L. sakei CRL1862, added separately, was used as
proteolytic enzyme source. The reaction mixture consisted of
3 ml of each suspension (WC and CFE) aseptically added to
30 ml of protein extract. The mixtures were incubated at 30 °C
in a shaken water bath and sampled at time 0 h and after 96 h
for further analyses. In each case, control samples without the
addition of any bacterial enzymes were assayed simulta-
neously. The extracts with different treatments were
centrifuged for 20 min at 14,000 rpm, and the supernatants
were collected for the experiments.
The analysis of generated peptides was performed by
RP-HPLC as follows: 4 ml of each sarcoplasmic or myofibrillar
extract was deproteinized with 10 ml of methanol, centrifuged
(10,000 rpm, 10 min, 4 °C), supernatants concentrated by evap-
oration to dryness and resuspended in deionizedwater. Peptide
extracts were analyzed at day 0 and after 96 h of incubation,
using a 1050 high-performance liquid chromatograph (Agilent,
Palo Alto, CA, USA) equipped with a photodiode array detector
and manual injector. A 4.6 × 250 mm Symmetry C18 column
(Waters, Milford, MA, USA) was used. The mobile phase
consisted of solvent A (0.1% trifluoroacetic acid in water) and
solvent B (acetonitrile–water–trifluoroacetic acid [60:40:0.085,
vol/vol/vol]). The elution was performed as follows: an isocratic
phase in 1% solvent B for 5 min, followed by a linear gradient
from 1 to 100% solvent B for 55 min, at a flow rate of 1.0 ml/min
at 40 °C. Peptides were detected at 214 nm.
2.4. Assay for ACE inhibitory activity
The fractions were collected, dried and re-dissolved in 70 μl of
150 mM Tris-base buffer (pH 8.3). The ACE inhibitory activity
of each fraction was measured according to procedures
described previously [17]. This assay is based on the ability of
ACE to hydrolyze the internally quenched fluorescent sub-
strate o-aminobenzoylglycyl-p-nitro-L-phenylalanyl-L-proline
(Abz-Gly-Phe-(NO2)-Pro). A sample solution (50 μl) was mixed
with 50 μl of 150 mM Tris-base buffer (pH 8.3) containing
Table 1 – Cell count (±SD) in meat extracts incubated at
30 °C for 96 h.
Cells count (CFU/ml) ± SD
Sarcoplasmic Myofibrillar
0 96 0 96
L. sakei
CRL1862
9.72 ± 0.19a 8.21 ± 0.15a 9.37 ± 0.18a ND
L. curvatus
CRL705
9.50 ± 0.16a 7.41 ± 0.18b 9.24 ± 0.14a 2.39 ± 0.17c
Control ND ND ND ND
Means with different letters in the same column differ significantly
(P < 0.05); ND: not detectable.
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10 min at 37 °C. The reaction was initiated by the addition of
200 μl of 150 mM Tris–HCl buffer (pH 8.3) containing 1.125 M
NaCl and 10 mM Abz-Gly-Phe-(NO2)-Pro and preincubated
10 min at 37 °C. Finally the reaction mixture was incubated
for 45 min at 37 °C. The generation of fluorescence due to the
release of o-aminobenzoylglycine (Abz-Gly) by the action of
ACE was measured using excitation and emission wave-
lengths of 355 and 405 nm, respectively. ACE inhibition of
each collected fraction is expressed as percentage.
2.5. Elucidation of the peptide sequence by tandem mass
spectrometry
Identification of the peptide sequence from fractions exhibiting
remarkable ACE inhibitory activity was carried out by MS/MS
analysis using an Ultimate Plus/Famos nano LC system (LC
Packings, Amsterdam, The Netherlands) and a QSTAR XL hybrid
quadrupole-TOF instrument (ABSCIEX, CA,USA) equippedwith a
nanoelectrospray ion source (Protana, Odense, Denmark). Frac-
tions obtained from RP-HPLC fractionation showing the highest
ACE inhibitory activity were concentrated using a speed-vac.
Peptides were then desalted using C18 pipette tips and diluted in
60 μl of loading buffer (0.1% of formic acid and 2% of aceto-
nitrile in water). Diluted samples were pre-concentrated on a
0.3 × 5 mm, 3 μm, C18 trap column from LC Packings PepMap
(Dionex Company, Amsterdam, The Netherlands) at a flow rate
of 40 μl/min andusing 0.1%of trifluoroacetic acid (TFA) asmobile
phase. After 3 min of pre-concentration, the trap column was
automatically switched in-line with a 0.075 × 150 mm, 3 μm,
Dionex C18 PepMap column from LC Packings. Mobile phases
consisted of solvent A, containing 0.1% formic acid in water and
solvent B containing 0.1% formic acid in 95% acetonitrile.
Chromatographic conditions were a linear gradient from 95% to
50% solvent A in 30 min at a flow rate of 0.2 ml/min. The column
outlet was directly coupled to a nano-eletrospray ion source
(Protana, Odense, Denmark) using a 15 μm PicoTip EMITTER
SilicaTip needle (New Objective, Massachusetts, USA). The
positive TOF mass spectra were recorded on the QSTAR
instrument using information dependent acquisition (IDA). TOF
MS survey scan was recorded for mass range m/z 350–1800
followed by MS/MS scans of the three most intense peaks.
Typical ion spray voltage was in the range of 2.5–3.0 kV, and
nitrogen was used as collision gas. Other source parameters and
spray position were optimized with a tryptic digest of protein
mixture digest (LC Packings; P/N 161088). Interpretation of
obtained MS/MS spectra was performed using an in-house 2.3
Mascot search engine version (Matrix Science, London, England)
in combination with searches on UniProtKB/Swiss-Prot protein
database. Mascot.dll 1.6b25 and ABSciex.DataAccess.Wiff File
DataReader.dll were used for importing data toMascot. Searches
were donewith the “none” enzyme specificity and a tolerance on
the mass measurement of 0.7 Da in MS mode and 0.5 Da for
MS/MS ions. Deamidation of Asn-Gln and oxidation of Met were
used as variable modifications.
2.6. Statistical analysis
Each experiment was performed on two separate replications.
One-way analysis of variance (ANOVA) was used (MinitabStatistic Program, release 8.21; Minitab Inc., Philadelphia, PA,
USA).3. Results and discussion
Cell counts in pork sarcoplasmic and myofibrillar meat
protein extracts, both inoculated with L. sakei CRL1862 or
L. curvatus CRL705 (WC + CFE), showed initial numbers of
approximately 109 CFU/ml. After 96 h of incubation at 30 °C, a
decline to 8.21 log CFU/ml and undetectable levels for L. sakei
CRL1862 were found in sarcoplasmic and myofibrillar extracts
respectively, while decreases to 7.41 (sarcoplasmic) and 2.39
(myofibrillar) log CFU/ml were observed for L. curvatus CRL705
(Table 1). These results are in agreement with those previously
reported by Fadda et al. [15], in which L. curvatus CECT904 and
L. sakei CECT4808 (WC + CFE) incubated on sarcoplasmic pro-
teins under similar conditions yielded higher final viabilities
than myofibrillar extracts. On the other hand, the combined
WC and CFE suspensions inoculated on myofibrillar extracts in
this study exhibited the same trend as was reported by Sanz
et al. [14].
L. sakei CRL1862 and L. curvatus CRL705 were reported to
exert antimicrobial activity [18,19]. With the aim to use these
strains as potential functional cultures in meat products, the
evaluation of their protein hydrolytic ability as well as
bioactive peptides generation (in particular ACE inhibitory
activity) from pork sarcoplasmic and myofibrillar proteins
was carried out. A biochemical approach is presented in this
work using proteolytic enzymes available in both WC and CFE
suspensions with the objective to enhance the proteolytic
activity on meat proteins. In fact, CFE from different micro-
organisms were applied as an additional enzyme source to
achieve higher availability of small peptides and free amino
acids in dry fermented sausages [20].
The resulting peptide patterns obtained from the proteo-
lytic activity of L. sakei CRL1862 and L. curvatus CRL705 on
sarcoplasmic proteins are shown in Fig. 1. The RP-HPLC
profiles from these extracts showed minor differences be-
tween 0 and 96 h in control samples (Fig. 1A,B) when
compared to those inoculated with the combination of WC
and CFE from L. sakei CRL1862 (Fig. 1C) and L. curvatus CRL705
(Fig. 1D). Indeed, inoculated extracts showed great peptide
generation between 15 and 40 min and the disappearance of
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Fig. 1 – RP-HPLC separation of fractions from sarcoplasmic protein extract. Control samples at 0 (A) and 96 h (B) of incubation;
samples inoculated with L. sakei CRL1862 (WC + CFE) at 96 h (C); samples inoculated with L. curvatus CRL705 (WC + CFE) at
96 h (D) of incubation at 30 °C. Arrows indicate active fractions. Chromatography conditions were performed as described in
the Materials and methods.
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of incubation. It has been reported that peptides rich in
hydrophobic amino acids and present in the medium–high
retention time region of a chromatogram on C18 reverse
phase column may exhibit ACE inhibitory activity [21].
Myofibrillar extracts showed similar results than those for
sarcoplasmic protein extracts, since again no significant
changes were found between myofibrillar control samples at
times 0 and 96 h (Fig. 2A,B). During 96 h of incubation with the
addition of WC and CFE from L. sakei CRL1862 and L. curvatus
CRL705, some new peaks were generated by both organisms
like those at 12, 19 and 28 min of retention time (Fig. 2C,D).
However, the generation of peptides from sarcoplasmic
proteins was much higher than that from myofibrillar. InTime (min) 
0 10 20 30 40 50 60
0 10 20 30 40 50 60
Ab
so
rb
an
ce
 2
14
 n
m
0
500
1000
1500
2000
2500
3000
3500
Ph
as
e 
B 
(%
)
0
20
40
60
80
100
120
Time (min) 
Ab
so
rb
an
ce
 2
14
 n
m
0
500
1000
1500
2000
2500
3000
3500
Ph
as
e 
B 
(%
)
0
20
40
60
80
100
120
A
C
Fig. 2 – RP-HPLC separation patterns of soluble peptides containe
96 h (B) of incubation; samples inoculated with L. sakei CRL1862
CRL705 (WC + CFE) at 96 h (D) of incubation at 30 °C. Chroma
Materials and methods.coincidence with these results, lactobacilli strains were
reported to hydrolyze pork sarcoplasmic proteins while a
lack of proteolytic activity was detected on myofibrillar
extracts [22]. In contrast, an intense hydrolysis of myofibrillar
proteins during fermentation and drying stages of pork
sausages using a mixed starter culture (LAB and Staphylococcus
strains) was found by Aro Aro et al. [23] and Hughes et al. [24].
When the ACE inhibitory activity was determined, only the
hydrolysates derived from sarcoplasmic proteins by the
action of L. sakei CRL1862 and L. curvatus CRL705 resulted to
be active. Peptides generated by L. sakei CRL1862 from sarco-
plasmic extracts after 96 h of incubation showed inhibitory
activities toward ACE of 54% ± 2.3 and 50% ± 3.1 in 27 and
32 min fractions, respectively (Fig. 1C). Also high percentages0 10 20 30 40 50 60
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d in myofibrillar protein extract. Control samples at 0 (A) and
(WC + CFE) at 96 h (C); samples inoculated with L. curvatus
tography conditions were performed as described in the
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fractions eluting at 32 and 34 min from L. curvatus CRL705
hydrolysates (Fig. 1D). The remaining collected fractions did
not exert a remarkable ACE inhibition. Similar ACE inhibitory
activities from sarcoplasmic proteins isolated from bovine
muscles were found using thermolysin + proteinase A and
papain enzymes [25,26]. In addition, when L. fermentum SM 605
was used as enzyme source on marine proteins, high ACE
inhibitory activity particularly during fermentation of marine
shrimp (A. chinensis) was obtained [11].
The identification of peptides contained in fractions 27 and
32 (Fig. 1C) and fractions 32 and 34 (Fig. 1D) was carried out
through MS/MS ion search using the Mascot search engine
and UniProtKB/Swiss-Prot protein database. Results from
peptide sequencing were subjected to a manual evaluation
as described by Chen et al. [27]; the validated sequences
explained all the major peaks found in the full MS spectrum.
The active ACE inhibitory fractions containing one or more
peptides, their respective molecular masses and sequences,
are listed in Tables 2 and 3. A search of potential biological
activity that can be derived from the identified peptides was
carried out with the BioPep database and by comparison with
sequences previously reported [28,29]. Fraction 27, obtained
from sarcoplasmic proteins by the action of L. sakei CRL1862
showed the highest ACE inhibition activity (54%), yielding
only one peptide sequence (FISNHAY), whereas a total of 17
peptides were identified from fraction 32 of the same extract.
On the other hand, 50 peptides were characterized from theTable 2 – Bioactive peptides identified from pork sarcoplasmic
96 h at 30 °C.
Fraction Obs mass
(Da) charge
state
Calc
mass
Identified peptide
containing the
sequence
Protein
27 426.2112+ 850.4 FISNHAY Fructose-bis
(Bos taurus)
32 377.22+ 752.4 AMQKIF oxidation (M)b Beta-enolas
631.362+ 1891.05 LKTAIQAAGYPDKV
oxidation (M);
deamidated (NQ)c
Beta-enolas
638.852+ 1275.68 IKNYPVVSIED Beta-enolas
496.592+ 1486.77 AAVYKALSDHHIY Fructose-bi
442.722+ 883.43 SDHHIYL Fructose-bis
717.352+ 1432.69 LSGGQSEEEASINL Fructose-bi
557.32+ 1112.58 TFSYGRALQA Fructose-bi
426.2112+ 850.4 FISNHAY Fructose-bis
669.431+ MVLPPP Thrombosp
protein 1 (T
440.742+ 879.48 VGLDTTKF Hydroxyacy
(HCDH_PIG)
502.782+ 1003.55 VGGASLKPEF Triosephosp
430.262+ 858.5 SPLPVIPH LIM domain
435.772+ 869.53 MPQQIGVP Serine/thre
547.782+ 1093.54 KETPSGFTLD Creatine kin
731.4 1+ VIQTGVD Creatine kin
542.292+ 1082.58 YYKATEPVI Adenylate k
388.232+ 774.44 PAKIEAF
a BioPep database.
b Oxidation.
c Deamidation.two most active fractions originated by L. curvatus CRL705, 30
from fraction 32 and 20 from fraction 34 (Table 3). Indeed, both
fractions corresponding to a retention time of 32 min were
found to be coincident for LAB strains in terms of ACE
inhibitory activity; however, as shown in Tables 2 and 3, the
nature of peptides contained in them differs significantly.
In general, all the peptides identified from the 4 analyzed
fractions showed a prevalence of hydrophobic and neutral
residues in the penultimate and ultimate C-terminal position.
It has been reported that at penultimate C-terminal position,
aliphatic (V, I, and A), basic (R) and aromatic (Y and F) residues
are frequently found in ACE inhibitory peptides, while
aromatic (W, Y, and F), proline (P) and aliphatic (I, A, L and
M) residues are preferred at the ultimate C-terminal end of
peptides [30]. In addition, peptides consisting of 6–14 amino
acid residues were identified (Tables 2 and 3), which are in
coincidence with ACE inhibitory peptides containing this
numbers of residues reported by Byun and Kim [31]. Although
small peptides (tri or tetra) were described to be more easily
absorbed in the intestinal tract than larger peptides [32],
evidence that large peptides could also be absorbed through
the small intestine wall of rats was previously reported [33]. In
this study, L. sakei CRL1862 as shown in Table 3 was able to
generate the unique peptide FISNHAY in fraction 27. The
heptapeptide FISNHAY, rather than having a proline residue,
has aliphatic (alanine) and aromatic (tyrosine) residues at the
penultimate and ultimate C-terminal positions, respectively;
this peptide sequence has not yet been found in other proteinproteins by the hydrolytic action of L. sakei CRL1862 during
origin (UniProtKB/Swiss-Prot
protein entry name)
ACE inhibitory sequences
reported in the
literaturea
phosphate aldolase AY
e (ENOB_BOVIN) IF,QF
e (ENOB_BOVIN) GY,YP,AA,AG,AI
e (ENOB_BOVIN) YP,NY,IE
sphosphate aldolase (ALDOA_RABIT) IY,VY,AA,YK,KA
phosphate aldolase (ALDOA_RABIT) IY,YL
sphosphate aldolase (ALDOA_RABIT) GQ,GG,SG,EA
sphosphate aldolase (ALDOA_RABIT) YG,RA,GR,SY,LQ,TF
phosphate aldolase (ALDOA_RABIT) AY
ondin type-1 domain-containing
HSD1_MOUSE)
VLP,LPP,PP
l-coenzyme A dehydrogenase VG,GL,KF
hate isomerase (TPIS_BOVIN) LKP,VG,GA,GG,KP
-binding protein 3 (LDB3_MOUSE) PLP,PL,IP,PH
onine-protein kinase (WNK1_MOUSE) IG,GV,PQ
ase M-type (KCRM_BOVIN) GF,SG,KE
ase M-type (KCRM_BOVIN) GV,TG
inase isoenzyme (KAD1_BOVIN) YK,KA,TE
AF,EA,IE
Table 3 – Bioactive peptides identified from pork sarcoplasmic proteins by the hydrolytic action of L. curvatus CRL705 during
96 h at 30 °C.
Fraction Obs mass
(Da) charge
state
Calc
mass
Identified peptide
containing the
sequence
Parent protein ACE inhibitory sequence
reported in the
literature a
32 502.782+ 1003.55 VGGASLKPEF Triosephosphate isomerase (TPIS_BOVIN) LKP,VG,GA,GG,KP
440.752+ 879.48 VGLDTTKF Hydroxyacyl-coenzyme A dehydrogenase
(HCDH_PIG)
VG,GL,KF
500.782+ 999.55 EVGGEALGRL Hemoglobin subunit beta (HBB_CALTO) VG,GR,GE,GG,LG,EA,EV
417.272+ 832.53 QLGKAGIM Neurochondrin (NCDN_BOVIN) GI,AG,GK,LG,KA
615.341+ ASDPIL Pyruvate kinase isozymes M1/M2 (KPYM_RAT)
601.342+ 1200.66 ASDPILYRPVA Pyruvate kinase isozymes M1/M2 (KPYM_RAT) LY,RP
464.792+ 927.57 PILYRPVA Pyruvate kinase isozymes M1/M2 (KPYM_RAT) LY,RP
515.732+ 1029.46 SKHPGDFGAD Myoglobin (MYG_PIG) GA,FG,GD,PG,HP
669.421+ IVPIVE Fructose-bisphosphate aldolase A
(ALDOA_RABIT)
VP,VE
496.63+ 1486.78 AAVYKALSDHHIY Fructose-bisphosphate aldolase A
(ALDOA_RABIT)
IY,VY,AA,YK,KA
717.372+ 1432.72 LSGGQSEEEASINL Fructose-bisphosphate aldolase A
(ALDOA_RABIT)
GQ,GG,SG,EA,
426.2112+ 850.4 FISNHAY Fructose-bisphosphate aldolase A
(ALDOA_RABIT)
AY
430.262+ 858.5 SPLPVIPH LIM domain-binding protein 3 (LDB3_MOUSE) PLP,PL,IP,PH
430.272+ 1287.8 KLDVKGKRVVM Phosphoglycerate kinase 1 (PGK1_BOVIN) VK,KR,KG,GK,KL
464.722+ 927.43 MSHLGRPD Phosphoglycerate kinase 1 (PGK1_BOVIN) GRP,RP,HL,GR,LG
541.282+ 1080.54 IKWGDAGATY Glyceraldehyde-3-phosphate dehydrogenase
(G3P_PIG)
KW,GA,AG,DA,WG,GD
654.28 GDAGATY Glyceraldehyde-3-phosphate dehydrogenase
(G3P_PIG)
GA,AG,DA,GD
837.44 VVESTGVF Glyceraldehyde-3-phosphate dehydrogenase
(G3P_PIG)
VF,GV,TG,VE
511.772+ 1021.53 GYSNRVVDL Glyceraldehyde-3-phosphate dehydrogenase
(G3P_PIG)
GY
377.22+ 752.4 AMQKIF Beta-enolase (ENOB_BOVIN) IF,QK
594.792+ 1187.57 DSRGNPTVEVD Beta-enolase (ENOB_BOVIN) EV,VE,PT
331.72+ 661.39 KVVIGM Beta-enolase (ENOB_BOVIN) IG,GM
534.3 VVIGM Beta-enolase (ENOB_BOVIN) IG,GM
638.852+ 1275.69 IKNYPVVSIED Beta-enolase (ENOB_BOVIN) YP,NY,IE
519.32+ 1036.59 NTNHGRILL Glucose-6-phosphate isomerase (G6PI_PIG) GR,HG
420.752+ 839.49 GTHIAKTL Glucose-6-phosphate isomerase (G6PI_PIG) IA,GT,IAK
513.792+ 1025.38 PSAVAKHFVA Glucose-6-phosphate isomerase (G6PI_PIG)
731.4 VIQTGVD Creatine kinase M-type GV,TG
508.28 VGSVF Creatine kinase M-type VF,VG,GS
435.772+ 869.53 GGKDQRLP Membrane metallo-endopeptidase-like 1
(MMEL1_MOUSE)
RL,GK,GG
34 559.33 1116.64 LVGGASLKPEF Triosephosphate isomerase (TPIS_BOVIN) LKP,VG,GA,GG,KP
323.222+ 644.43 KSLLGK Phosphoglycerate kinase 1 (PGK1_BOVIN) GK,LG
380.742+ 759.46 KSLLGKD Phosphoglycerate kinase 1 (PGK1_BOVIN) GK,LG
486.822+ 971.62 KSLLGKDVL Phosphoglycerate kinase 1 (PGK1_BOVIN) GK,LG
649.392+ 1296.78 LEGKVLPGVDALS Phosphoglycerate kinase 1 (PGK1_BOVIN) VLP,LPG,DA,GV,GK,EG,PG
527.283+ 1578.83 PFGNTHNKYKLNF Creatine kinase M-type (KCRM_PIG) FG,NF,KY,YK,NK,LN
407.712+ 813.41 PGHPFIM Creatine kinase M-type (KCRM_PIG) GH,PG,HP
380.22+ 758.38 IDDHFL Creatine kinase M-type (KCRM_PIG)
377.252+ 752.49 KPVSPLL Creatine kinase M-type (KCRM_PIG) VSP,PL,KP
751.42 TAAVGSVF Creatine kinase M-type (KCRM_PIG) VF,AA,VG,GS
495.292+ 988.57 LVVDGVKLM (M)b Creatine kinase M-type (KCRM_PIG) VK,GV,DG,KL
475.292+ 948.56 YVTAIRNL Serotransferrin (TRFE_HORSE) IR,AI
314.72+ 627.39 VILFH Fructose-bisphosphate aldolase A
(ALDOA_RABIT)
LF
534.33+ 1599.88 AAVYKALSDHHIYL Fructose-bisphosphate aldolase A
(ALDOA_RABIT)
IY,VY,YL,AA,YK,KA
453.923+ 1358.74 YKALSDHHIYL Fructose-bisphosphate aldolase A
(ALDOA_RABIT)
IY,YL,YK,KA
483.252+ 964.49 FISNHAY (NQ)c Fructose-bisphosphate aldolase A
(ALDOA_RABIT)
AY
547.82+ 1093.59 VDTSKGFLID Adenylate kinase isoenzyme (KAD1_BOVIN) GF,KG
549.852+ 1097.68 PILYRPVAVA Pyruvate kinase isozymes (KPYM_RABIT) LY,RP,VAV
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Table 3 (continued)
Fraction Obs mass
(Da) charge
state
Calc
mass
Identified peptide
containing the
sequence
Parent protein ACE inhibitory sequence
reported in the
literature a
34 478.263+ 1431.76 QQAVRAIVSCFPN Beta-1,3-galactosyl-O-glycosyl-glycoprotein
beta-1,6-N-acetylglucosaminyltransferase
(GCNT3_RAT)
FP,RA,VR,CF,AI
545.832+ 1089.64 QLVMFVLQL Anion exchange transporter (S26A7_MOUSE) MF,LQ
a BioPep database.
b Oxidation.
c Deamidation.
189J O U R N A L O F P R O T E O M I C S 8 9 ( 2 0 1 3 ) 1 8 3 – 1 9 0hydrolysates with ACE inhibitory activity. In addition, the
peptide VGGASLKPEF generated by both L. sakei CRL1862 and
L. curvatus CRL705 (fraction 32) and the peptide LVGGASLKPEF
generated by L. curvatus CRL705 in fraction 34 showed the
bioactive tripeptide LKP [30] encrypted in their sequences.
Similarly, this bioactive sequence was also found in the
peptide LKPNM derived from dried bonito muscle digested
with thermolysin, which has been reported to exhibit ACE
inhibitory activity [34]. In particular, when fractions generated
by L. curvatus CRL705 from sarcoplasmic proteinswere analyzed,
the peptides PILYRPVA and VVIGM identified from fraction 32
matched as part of the longer peptides ASDPILYRPVA and
KVVIGM, respectively, which were also found in this fraction.
Moreover, the peptides originated from phosphoglycerate ki-
nase, KSLLGKD and KSLLGKDVL differing in one and two amino
acid, respectively and the peptide KSLLGK which were found to
share a strong homology were identified from the fraction 34.
Notably, ACE inhibitory activity was similar in all four active
fractions containing the peptide FISNHAY. Because this peptide
was the only identified from the fraction 27, the observed
inhibitory activity in the remaining fractions may be attributed
to thispeptide.Moreover the large amount of peptides generated
from sarcoplasmic extracts confirm the existence of remarkable
exopeptidase activities in the cell suspensions of L. sakeiCRL1862
and L. curvatus CRL705, as was previously pointed out [35,19].4. Conclusions
This study demonstrated that antihypertensive activity can
be generated from porcine proteins fermentation by using
lactic acid bacteria, through the release of ACE inhibitory
peptides. The generated bioactive peptides by L. sakei CRL1862
and L. curvatus CRL705 may be used to develop physiologically
functional foods, giving rise to new market for healthier meat
products. In this way, further studies must be carried out in
order to evaluate in vivo the antihypertensive activity of the
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